FDA – Page 74 – Pharma.Tips

Supplier change unqualified during audit – CAPA and system remediation

Understanding and Investigating Unqualified Supplier Changes During Audits In pharmaceutical manufacturing, a significant challenge arises when supplier changes are deemed unqualified during an audit. This scenario can raise compliance concerns…

CSV not aligned to actual use during validation lifecycle – inspection evidence pack preparation

Investigation into CSV Misalignment with Actual Use During the Validation Lifecycle In the realm of pharmaceutical manufacturing and quality control, one prevalent challenge faced by organizations is the misalignment of…

Distribution temperature breach during inspection – product quality risk assessment

“`html Assessing the Risks of Distribution Temperature Breach During Inspection In the pharmaceutical industry, maintaining the integrity of temperature-sensitive products during distribution is critical. A distribution temperature breach can lead…

Audit trail gaps identified during data integrity review – inspection evidence pack preparation

Managing Audit Trail Gaps from Data Integrity Reviews in Pharma The integrity of data is paramount in pharmaceutical manufacturing and quality operations, particularly in light of regulatory scrutiny. Gaps in…

Supplier change unqualified during transportation – documentation pack for auditors

“`html Investigation of Unqualified Supplier Change During Transportation Pharmaceutical companies must maintain stringent compliance protocols during the transportation of materials. One frequently encountered problem is the qualification of suppliers, especially…

Patch management weaknesses during inspection walkthrough – data integrity risk and remediation

Identifying and Addressing Patch Management Weaknesses During Inspection Walkthroughs Poor patch management can expose pharmaceutical manufacturers to significant compliance risks, particularly during regulatory inspections conducted by agencies such as the…

Inventory control failure during storage – documentation pack for auditors

Understanding and Investigating Inventory Control Failures in Pharmaceutical Storage Inventory control failures during storage can pose significant risks to pharmaceutical manufacturers, impacting product quality, compliance, and ultimately patient safety. This…

Interface validation gaps during system operation – CAPA and revalidation strategy

Addressing Gaps in Interface Validation during System Operation: A Comprehensive CAPA and Revalidation Approach In the intricate world of pharmaceutical manufacturing, ensuring the integrity and reliability of software and systems…

Container closure integrity risk during inspection readiness – regulatory risk analysis and mitigation

Analyzing Container Closure Integrity Risks During Inspection Readiness Container closure integrity (CCI) is a critical quality attribute in pharmaceutical manufacturing, as it directly impacts product sterility and stability. Instances of…

Interface validation gaps during system upgrades – CAPA and revalidation strategy

Addressing Validation Gaps in Interfaces During System Upgrades: An Investigation Approach As pharmaceutical companies adopt new technologies, system upgrades can often lead to interface validation gaps that compromise data integrity…

Material specification drift during scale-up – documentation gaps regulators question

Investigating Material Specification Drift During Scale-Up for Enhanced Compliance Material specification drift during scale-up poses significant challenges for pharmaceutical manufacturing organizations. When the specifications of raw materials shift unintentionally during…

Patch management weaknesses during system upgrades – data integrity risk and remediation

Identifying and Addressing Patch Management Weaknesses During System Upgrades in Pharma In today’s increasingly regulated pharmaceutical landscape, effective management of IT systems is critical to safeguarding data integrity and ensuring…